These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 30015868)

  • 1. NT21MP negatively regulates paclitaxel-resistant cells by targeting miR‑155‑3p and miR‑155-5p via the CXCR4 pathway in breast cancer.
    Wang Y; Yan L; Zhang L; Xu H; Chen T; Li Y; Wang H; Chen S; Wang W; Chen C; Yang Q
    Int J Oncol; 2018 Sep; 53(3):1043-1054. PubMed ID: 30015868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-peptide of vMIP-Ⅱ reverses paclitaxel-resistance by regulating miRNA-335 in breast cancer.
    Wang Y; Wang H; Ding Y; Li Y; Chen S; Zhang L; Wu H; Zhou J; Duan K; Wang W; Chen C; Yang Q
    Int J Oncol; 2017 Sep; 51(3):918-930. PubMed ID: 28731125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer.
    Li Y; Zhang L; Dong Z; Xu H; Yan L; Wang W; Yang Q; Chen C
    Pathol Res Pract; 2021 Apr; 220():153405. PubMed ID: 33756128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N-terminal polypeptide derived from viral macrophage inflammatory protein II reverses breast cancer epithelial-to-mesenchymal transition via a PDGFRα-dependent mechanism.
    Yang QL; Zhang LY; Wang HF; Li Y; Wang YY; Chen TT; Dai MF; Wu HH; Chen SL; Wang WR; Wu Q; Chen CJ; Zhou CZ
    Oncotarget; 2017 Jun; 8(23):37448-37463. PubMed ID: 28415580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumour activity of the recombination polypeptide GST-NT21MP is mediated by inhibition of CXCR4 pathway in breast cancer.
    Yang Q; Zhang F; Ding Y; Huang J; Chen S; Wu Q; Wang Z; Wang Z; Chen C
    Br J Cancer; 2014 Mar; 110(5):1288-97. PubMed ID: 24448360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Qiu Y; Yagüe E; Ji W; Liu J; Zhang J
    Cell Death Dis; 2016 Jun; 7(6):e2291. PubMed ID: 27362808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The N-terminal polypeptide derived from vMIP-II exerts its antitumor activity in human breast cancer through CXCR4/miR-7-5p/Skp2 pathway.
    Wang HF; Dong ZY; Yan L; Yang S; Xu HN; Chen SL; Wang WR; Yang QL; Chen CJ
    J Cell Physiol; 2020 Dec; 235(12):9474-9486. PubMed ID: 32372405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel.
    Zhang HD; Sun DW; Mao L; Zhang J; Jiang LH; Li J; Wu Y; Ji H; Chen W; Wang J; Ma R; Cao HX; Wu JZ; Tang JH
    Biochem Biophys Res Commun; 2015 Oct; 465(4):702-13. PubMed ID: 26299922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells.
    Yang Q; Wang Y; Lu X; Zhao Z; Zhu L; Chen S; Wu Q; Chen C; Wang Z
    Oncotarget; 2015 Feb; 6(5):3268-79. PubMed ID: 25605244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer.
    Wang W; Zhang L; Wang Y; Ding Y; Chen T; Wang Y; Wang H; Li Y; Duan K; Chen S; Yang Q; Chen C
    Cell Death Dis; 2017 Oct; 8(10):e3071. PubMed ID: 28981108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-155-3p acts as a tumor suppressor and reverses paclitaxel resistance via negative regulation of MYD88 in human breast cancer.
    Zhang L; Chen T; Yan L; Xu H; Wang Y; Li Y; Wang H; Chen S; Wang W; Chen C; Yang Q
    Gene; 2019 Jun; 700():85-95. PubMed ID: 30878390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA LINC00662 promotes proliferation and migration of breast cancer cells via regulating the miR-497-5p/EglN2 axis.
    Cheng L; Xing Z; Zhang P; Xu W
    Acta Biochim Pol; 2020 Jun; 67(2):229-237. PubMed ID: 32558530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of MyD88 and association with paclitaxel resistance in breast cancer.
    Xiang F; Ni Z; Zhan Y; Kong Q; Xu J; Jiang J; Wu R; Kang X
    Tumour Biol; 2016 May; 37(5):6017-25. PubMed ID: 26596839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer.
    Shen Y; Ye YF; Ruan LW; Bao L; Wu MW; Zhou Y
    Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-574 enhances doxorubicin resistance through down-regulating SMAD4 in breast cancer cells.
    Sun FD; Wang PC; Luan RL; Zou SH; Du X
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1342-1350. PubMed ID: 29565492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of breast cancer proliferation and induction of apoptosis via AKT and ERK1/2 signal transduction pathways by synthetic polypeptide derived from viral macrophage inflammatory protein II.
    Yang Q; Chen C; Yang Z; Gao Y; Tang J
    J Huazhong Univ Sci Technolog Med Sci; 2011 Aug; 31(4):497. PubMed ID: 21823011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-30e inhibits tumor growth and chemoresistance via targeting IRS1 in Breast Cancer.
    Liu MM; Li Z; Han XD; Shi JH; Tu DY; Song W; Zhang J; Qiu XL; Ren Y; Zhen LL
    Sci Rep; 2017 Nov; 7(1):15929. PubMed ID: 29162879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bifunctional fused polypeptide inhibits the growth and metastasis of breast cancer.
    Liang AL; Qian HL; Zhang TT; Zhou N; Wang HJ; Men XT; Qi W; Zhang PP; Fu M; Liang X; Lin C; Liu YJ
    Drug Des Devel Ther; 2015; 9():5671-86. PubMed ID: 26527862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The mechanism of polypeptide derived from viral macrophage inflammatory protein II modulates SDF-1α/CXCR4-induced migration].
    Yang QL; Ding YX; Chen CJ; Yang ZF; Gao YJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Feb; 28(2):137-40. PubMed ID: 22304770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL; Zhang ZJ; Yi ZB; Li JJ
    Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.